Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 5/20 | 0.38 |
| ▸ | NPY4R | P50391 | 10/20 | 0.38 |
| ▸ | NPY1R | P25929 | 7/20 | 0.38 |
| ▸ | NPY2R | P49146 | 5/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.38 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.37 |
| ▸ | CTSC | P53634 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29540572 | 0.94 | NPY4R (0.39) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL11567334 | 0.94 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31643173 | 0.94 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL11569777 | 0.94 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL11567327 | 0.94 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31673514 | 0.93 | FURIN (0.39) | FURINNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL9819642 | 0.93 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL9819648 | 0.93 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29697049 | 0.93 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31110537 | 0.91 | FURIN (0.42) | FURINNPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12576168-B2 | Peptide PET/SPECT probes specific to oncoproteins in tumor extracellular matrix | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-03-17 | — | — | US | disclosed |
| CN-116555283-A | Japanese larch LkZFP36 gene and protein encoded by same, application, over-expression vector and acquisition method | 东北林业大学 | 2023-08-08 | — | — | CN | disclosed |
| US-20220160903-A1 | PEPTIDE PET/SPECT PROBES SPECIFIC TO ONCOPROTEINS IN TUMOR EXTRACELLULAR MATRIX | CASE WESTERN RESERVE UNIVERSITY | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160903-A1 | PEPTIDE PET/SPECT PROBES SPECIFIC TO ONCOPROTEINS IN TUMOR EXTRACELLULAR MATRIX | FN1, EDNRB, NGLY1 | FURIN 848/4885NPY4R 2610/4885NPY1R 795/4885 |
| US-12576168-B2 | Peptide PET/SPECT probes specific to oncoproteins in tumor extracellular matrix | FN1, INHA, EDNRB | FURIN 1511/4885NPY4R 2238/4885NPY1R 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.